George B. McDonald, James W. Freston, James L. Boyer, Laurie D. DeLeve – 18 August 2018 – Treatment of hematological malignancy with antibody‐drug conjugates (ADCs) may cause liver injury. ADCs deliver a toxic moiety into antigen‐expressing tumor cells, but may also injure hepatic sinusoids (sinusoidal obstruction syndrome; SOS).
Sungjin Ko, Satdarshan P. Monga – 18 August 2018
Sandy Feng, John Bucuvalas – 17 August 2018
Anjana Pillai – 17 August 2018
Lovkesh Anand, Ashok Choudhury, Chhagan Bihari, Barjesh C. Sharma, Manoj Kumar, Rakhi Maiwall, Soek Siam Tan, Samir R. Shah, Saeed Hamid, Amna S. Butt, Wasim Jafri, Yogesh K. Chawla, Sunil Taneja, Ajay Duseja, Radha K. Dhiman, Mamun Al Mahtab, Hasmik Ghazinyan, Zhongping Duan, Yu Chen, Akash Shukla, Jinhua Hu, Zaigham Abbas, Sombat Treeprasertsuk, Laurentius A. Lesmana, Cosmas R Lesmana, Jose D. Sollano, Gian Carpio, Manoj K. Sahu, Guresh Kumar, Shiv K.
Bo Kong, Grace L. Guo – 16 August 2018
Paloma Talayero, Esther Ramos Boluda, Elena Gómez Massa, María José Castro Panete, Gerardo Prieto Bozano, Francisco Hernández Oliveros, Manuel López Santamaría, Jorge Calvo Pulido, Estela Paz‐Artal, Esther Mancebo – 16 August 2018 – Rejection is one of the most important drawbacks for graft and patient survival in intestinal and multivisceral transplantation.
Jun‐feng Chen, Bing‐liang Lin – 14 August 2018
Ratna B. Ray, Ranjit Ray – 13 August 2018 – Chronic hepatitis C virus (HCV) infection‐associated liver disease is a global health problem. HCV often causes silent disease, and eventually progresses to end‐stage liver disease. HCV infects hepatocytes; however, initial manifestation of liver disease is mostly displayed in hepatic stellate cells (HSCs), causing fibrosis/cirrhosis, and is believed to occur from inflammation in the liver.
Ratna B. Ray, Ranjit Ray – 13 August 2018 – Chronic hepatitis C virus (HCV) infection‐associated liver disease is a global health problem. HCV often causes silent disease, and eventually progresses to end‐stage liver disease. HCV infects hepatocytes; however, initial manifestation of liver disease is mostly displayed in hepatic stellate cells (HSCs), causing fibrosis/cirrhosis, and is believed to occur from inflammation in the liver.